AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $124,000 | -78.1% | 12,531 | -48.8% | 0.00% | -66.7% |
| Q4 2020 | $565,000 | -96.7% | 24,468 | -98.8% | 0.00% | -96.9% |
| Q3 2019 | $16,921,000 | -79.8% | 2,109,899 | -68.5% | 0.10% | -81.5% |
| Q2 2019 | $83,718,000 | -52.1% | 6,708,228 | -47.8% | 0.52% | -16.1% |
| Q1 2019 | $174,896,000 | +243.4% | 12,860,038 | +141.9% | 0.62% | +25.8% |
| Q4 2018 | $50,930,000 | -31.4% | 5,316,284 | -13.4% | 0.49% | +93.3% |
| Q3 2018 | $74,200,000 | +2219.5% | 6,137,358 | +2896.7% | 0.26% | +1316.7% |
| Q2 2018 | $3,199,000 | +145.1% | 204,807 | +136.0% | 0.02% | +157.1% |
| Q1 2018 | $1,305,000 | -47.3% | 86,775 | -49.6% | 0.01% | -50.0% |
| Q4 2017 | $2,476,000 | -24.0% | 172,055 | -20.8% | 0.01% | -33.3% |
| Q3 2017 | $3,260,000 | – | 217,337 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |